Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
UBS
Federal Trade Commission
Fuji
US Army
Boehringer Ingelheim
Healthtrust
Chinese Patent Office
Colorcon
Cerilliant

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017624

« Back to Dashboard

NDA 017624 describes FORANE, which is a drug marketed by Baxter Hlthcare and is included in one NDA. It is available from one supplier. Additional details are available on the FORANE profile page.

The generic ingredient in FORANE is isoflurane. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the isoflurane profile page.
Summary for 017624
Tradename:FORANE
Applicant:Baxter Hlthcare
Ingredient:isoflurane
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 017624
Physiological EffectGeneral Anesthesia
Medical Subject Heading (MeSH) Categories for 017624
Suppliers and Packaging for NDA: 017624
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FORANE isoflurane LIQUID;INHALATION 017624 NDA Baxter Healthcare Corporation 10019-360 10019-360-60 6 BOTTLE, GLASS in 1 PACKAGE (10019-360-60) > 250 mL in 1 BOTTLE, GLASS
FORANE isoflurane LIQUID;INHALATION 017624 NDA Baxter Healthcare Corporation 10019-360 10019-360-40 6 BOTTLE, GLASS in 1 PACKAGE (10019-360-40) > 100 mL in 1 BOTTLE, GLASS

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:LIQUID;INHALATIONStrength99.9%
Approval Date:Approved Prior to Jan 1, 1982TE:ANRLD:Yes

Expired US Patents for NDA 017624

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter Hlthcare FORANE isoflurane LIQUID;INHALATION 017624-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Baxter Hlthcare FORANE isoflurane LIQUID;INHALATION 017624-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Accenture
QuintilesIMS
Federal Trade Commission
Daiichi Sankyo
US Army
Chinese Patent Office
Novartis
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot